Hanyang Med Rev.  2012 Aug;32(3):141-144. 10.7599/hmr.2012.32.3.141.

Recent Trends and Strategies in Stem Cell Therapy for Alzheimer's Disease

Affiliations
  • 1Biomedical Research Institute, MEDIPOST Co. Ltd., Seoul, Korea. jwc@medi-post.co.kr

Abstract

The human mesenchymal stem cell (MSC) has been regarded as a fascinating candidate of stem cell therapy in neurodegenerative disorders such as Alzheimer disease (AD). Recently, many groups reported that mesenchymal stem cell is a robust source, not only of regeneration, but also of secretion of various soluble factors for damaged or lost host cells. Several groups have observed paracrine action of mesenchymal stem cells in transgenic mice models of AD. From non-clinical studies we can conclude that human mesenchymal stem cells could participate in anti-apoptosis, beta-amyloid removal, anti-inflammation and anti-tau aggregation via paracrine action. Based on these findings, several clinical trials have been performed or completed worldwide. Since safety and efficacy have been confirmed from various non-clinical and clinical trials, we can expect emerging use of stem cells for AD in the near future.

Keyword

Alzheimer Disease; Mesenchymal Stem Cells; Paracrine

MeSH Terms

Alzheimer Disease
Animals
Humans
Mesenchymal Stromal Cells
Mice
Mice, Transgenic
Neurodegenerative Diseases
Regeneration
Stem Cells
Full Text Links
  • HMR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error